Acadia Healthcare (ACHC) – Analysts’ Recent Ratings Changes

Acadia Healthcare (NASDAQ: ACHC) has recently received a number of price target changes and ratings updates:

• 12/18/2025 – Acadia Healthcare had its price target lowered by analysts at Mizuho from $22.00 to $17.00. They now have a “neutral” rating on the stock.
• 12/4/2025 – Acadia Healthcare had its price target lowered by analysts at Barclays PLC from $17.00 to $14.00. They now have an “equal weight” rating on the stock.
• 12/3/2025 – Acadia Healthcare had its price target lowered by analysts at Royal Bank Of Canada from $22.00 to $19.00. They now have an “outperform” rating on the stock.
• 12/3/2025 – Acadia Healthcare was given a new $17.00 price target on by analysts at Cantor Fitzgerald.
• 12/3/2025 – Acadia Healthcare was given a new $17.00 price target on by analysts at Raymond James Financial, Inc..
• 12/3/2025 – Acadia Healthcare had its price target lowered by analysts at Cantor Fitzgerald from $22.00 to $17.00. They now have a “neutral” rating on the stock.
• 12/3/2025 – Acadia Healthcare had its price target lowered by analysts at UBS Group AG from $28.00 to $24.00. They now have a “buy” rating on the stock.
• 12/3/2025 – Acadia Healthcare had its price target lowered by analysts at KeyCorp from $30.00 to $25.00. They now have an “overweight” rating on the stock.
• 12/3/2025 – Acadia Healthcare had its price target lowered by analysts at Deutsche Bank Aktiengesellschaft from $33.00 to $20.00. They now have a “buy” rating on the stock.
• 12/3/2025 – Acadia Healthcare was downgraded by analysts at Leerink Partnrs from a “strong-buy” rating to a “hold” rating.
• 12/3/2025 – Acadia Healthcare was downgraded by analysts at Bank of America Corporation from a “neutral” rating to an “underperform” rating. They now have a $13.00 price target on the stock, down previously from $21.50.
• 12/3/2025 – Acadia Healthcare had its “market perform” rating reaffirmed by analysts at Leerink Partners. They now have a $14.00 price target on the stock, down previously from $25.00.
• 11/18/2025 – Acadia Healthcare had its price target lowered by analysts at KeyCorp from $35.00 to $30.00. They now have an “overweight” rating on the stock.
• 11/12/2025 – Acadia Healthcare had its price target lowered by analysts at Royal Bank Of Canada from $28.00 to $22.00. They now have an “outperform” rating on the stock.
• 11/10/2025 – Acadia Healthcare had its price target lowered by analysts at Guggenheim from $29.00 to $27.00. They now have a “buy” rating on the stock.
• 11/7/2025 – Acadia Healthcare was given a new $22.00 price target on by analysts at Raymond James Financial, Inc..
• 11/7/2025 – Acadia Healthcare had its price target lowered by analysts at Cantor Fitzgerald from $25.00 to $22.00. They now have a “neutral” rating on the stock.
• 11/7/2025 – Acadia Healthcare had its price target lowered by analysts at UBS Group AG from $31.00 to $28.00. They now have a “buy” rating on the stock.
• 11/6/2025 – Acadia Healthcare had its price target lowered by analysts at Barclays PLC from $20.00 to $17.00. They now have an “equal weight” rating on the stock.

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.